A detailed history of Principal Securities, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 967 shares of AMPH stock, worth $37,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares
967
Previous 731 32.28%
Holding current value
$37,848
Previous $29.2 Million 60.5%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$36.99 - $50.09 $8,729 - $11,821
236 Added 32.28%
967 $46.9 Million
Q2 2024

Jul 31, 2024

BUY
$38.65 - $43.48 $16,967 - $19,087
439 Added 150.34%
731 $29.2 Million
Q1 2024

May 10, 2024

SELL
$42.85 - $63.45 $10,969 - $16,243
-256 Reduced 46.72%
292 $12.8 Million
Q4 2023

Feb 07, 2024

BUY
$44.49 - $62.93 $24,380 - $34,485
548 New
548 $33.9 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.